The relationship between regulatory authorities and pharmaceutical companies may at first glance appear to be pulling in different directions, but …
The new GP contract was supported by a massive 79 per cent of those GPs who voted for it, despite …
Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about …
The crisis surrounding the proposed new GP contract has deepened after doctors refused to be "stampeded" into accepting a new …
Fred Hassan has announced a major re-organisation of Schering-Plough's pharmaceutical operations just 17 days after taking on the job of …
The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.Introduced in 1999, …
Roche and health call-centre specialists International SOS have launched the UK's first ever helpline to proactively support patients to keep …
Private sector companies have been invited to run the latest wave of new diagnostic treatment centres (DTC) to help cut …
The European Union medicines regulator is to investigate the safety of hormone replacement therapy products following a new study was …
A leading UK drug discovery centre is one of a number of global sites to close following Pfizer's recently completed …
A new type of cancer drug developed by Roche, Genentech and OSI Pharmaceuticals has failed to prove its efficacy in …